1. Freireich EJ (1997) Regulatory issues. In Cancer: Principles and Practice of Oncology, edn 5, 2966–2972 (Eds DeVita Jr VT et al.) Philadelphia: Lippincott–Raven
2. Hutt PB (1993) The regulation of pharmaceutical products in the USA. In Pharmaceutical Medicine, edn 2, 211 (Eds Burley DM et al.). Boston: Edward Arnold
3. Pharmaceutical research and manufacturers of America (online March 2005) Pharmaceutical industry profile 2005. From laboratory to patient: pathways to biopharmaceutical innovation. [
http://www.phrma.org/publications/publications/2005-03-17.1143.pdf
] (accessed 24 November 2005)
4. Freireich EJ and Bodey GP (1984) Evaluation of new agents: planning, execution and evaluation of clinical studies. In Clinical Chemotherapy, 115 (Eds Kuemmerle HP et al.) New York: Thieme-Stratton
5. Joravsky D (2005) Lysenkoism. In New Dictionary of the History of Ideas, 1321–1323 (Ed. Horowitz M) Detroit: Charles Scribner's Sons